APTORUM GROUP LIMITED
Last · —$8.41-75.76 (-90.01%)close · yahoo · 9h ago
Vol 34.5K ≈ 290.5K
Market cap$570062.00—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
Issuer
Legal nameAPTORUM GROUP LIMITED
HQUnited States (US)
ListingUS APM
ISINKYG6096M1226
SectorHealthcare
IndustryBiotechnology & Medical Research
SIC3829
CurrencyUSD
Entity registrylei:984500B8DA8D2D9BFA46
CIK0001734005
Websitewww.aptorumgroup.com
Employees1
AddressAptorum Group Ltd. 17 Hanover Square W1S 1BN, London +44 20 8092 9299
Loading chart…
OpenFilings analyst
Our analyst
20-F · 2026-03-27
From latest 20-F · 2026-03-27
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Runway Low
- Current Ratio Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -654.8%
- Cash Runway Low — Cash runway ~1.9 years
- Current Ratio Low — Current ratio 0.78
- Accumulated Deficit High — Accumulated deficit / equity 319%
Earnings transcripts
Press & signals
- GlobeNewswire
Aptorum Group Provides Update on DiamiR Biosciences Merger
- GlobeNewswire
Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer’s Disease Biomarkers
Documents
FormReporting forFiledFlags
Showing 5 of 33 filings